AFME Stock Overview
Develops minimally invasive medical devices in the field of urology and structural heart in France. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Affluent Medical SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.67 |
| 52 Week High | €2.30 |
| 52 Week Low | €1.23 |
| Beta | 0.58 |
| 11 Month Change | -3.20% |
| 3 Month Change | -12.37% |
| 1 Year Change | 32.14% |
| 33 Year Change | -72.30% |
| 5 Year Change | n/a |
| Change since IPO | -79.19% |
Recent News & Updates
Recent updates
Shareholder Returns
| AFME | FR Medical Equipment | FR Market | |
|---|---|---|---|
| 7D | -0.9% | 2.7% | -0.3% |
| 1Y | 32.1% | 26.7% | -3.5% |
Return vs Industry: AFME exceeded the French Medical Equipment industry which returned 28.4% over the past year.
Return vs Market: AFME exceeded the French Market which returned -2.5% over the past year.
Price Volatility
| AFME volatility | |
|---|---|
| AFME Average Weekly Movement | 5.9% |
| Medical Equipment Industry Average Movement | 5.4% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FR Market | 9.2% |
| 10% least volatile stocks in FR Market | 2.2% |
Stable Share Price: AFME has not had significant price volatility in the past 3 months compared to the French market.
Volatility Over Time: AFME's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 63 | Sebastien Ladet | www.affluentmedical.com |
Affluent Medical SA develops minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. The company was founded in 2011 and is based in Aix-en-Provence, France.
Affluent Medical SA Fundamentals Summary
| AFME fundamental statistics | |
|---|---|
| Market cap | €65.50m |
| Earnings (TTM) | -€17.04m |
| Revenue (TTM) | €1.30m |
50.6x
P/S Ratio-3.8x
P/E RatioIs AFME overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AFME income statement (TTM) | |
|---|---|
| Revenue | €1.30m |
| Cost of Revenue | €2.31m |
| Gross Profit | -€1.01m |
| Other Expenses | €16.03m |
| Earnings | -€17.04m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.43 |
| Gross Margin | -77.99% |
| Net Profit Margin | -1,315.91% |
| Debt/Equity Ratio | 54.4% |
How did AFME perform over the long term?
See historical performance and comparison